127 related articles for article (PubMed ID: 5139589)
1. [Effect of Inderal on intermittent claudication in patients with obliterative arterial disease].
Skawiński S; Wójcikiewicz O; Peiker W
Pol Tyg Lek; 1971 Dec; 26(52):2019-21. PubMed ID: 5139589
[No Abstract] [Full Text] [Related]
2. [Arterial insufficiency in the lower extremities treated with drugs].
Genster HG; Oram V
Ugeskr Laeger; 1971 Feb; 133(6):244-6. PubMed ID: 4926100
[No Abstract] [Full Text] [Related]
3. [Testosterone and the prostate gland].
Winther O
Nord Med; 1970 May; 83(20):624-6. PubMed ID: 5426430
[No Abstract] [Full Text] [Related]
4. Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
Clement DL
Verh K Acad Geneeskd Belg; 1980; 42(3-4):164-214. PubMed ID: 6114601
[No Abstract] [Full Text] [Related]
5. [On conserative treatment of arterial circulation disorders].
Hänel W
Ther Ggw; 1968 Apr; 107(4):546-8. PubMed ID: 5672326
[No Abstract] [Full Text] [Related]
6. The effect of hydroxyethylrutoside (HR) on peripheral blood flow: a preliminary report.
Fitzgerald DE; Butterfield WJ; Keates JS; Hodges M
Bibl Anat; 1969; 10():600-5. PubMed ID: 5407421
[No Abstract] [Full Text] [Related]
7. [Use of nitrendipine in treating patients with obliterative atherosclerosis of arteries in the lower extremities].
Grodzińska L; Kostka-Trabka E; Basista M; Bieroń K; Sławiński M; Telesz E
Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):598-600. PubMed ID: 1669121
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic arterial occlusions with streptokinase.
Poliwoda H; Alexander K; Buhl V; Holsten D; Wagner HH
N Engl J Med; 1969 Mar; 280(13):689-92. PubMed ID: 5766078
[No Abstract] [Full Text] [Related]
9. [Effect of beta receptor blockaders in arterial circulation disorders of the lower extremities].
Schaller K
Dtsch Gesundheitsw; 1970 Aug; 25(32):1513-4. PubMed ID: 4396421
[No Abstract] [Full Text] [Related]
10. [Streptokinase-streptodornase association, a powerful therapeutic agent affecting the venous factor in obliterating arteritis of the lower limbs].
Fux J; Cotin M
Phlebologie; 1970; 23(3):303-5. PubMed ID: 5475594
[No Abstract] [Full Text] [Related]
11. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
Marigo S
Clin Ter; 1980 Jun; 93(5):503-18. PubMed ID: 7428314
[No Abstract] [Full Text] [Related]
12. [Intermittent claudication: topical treatment with isosorbide dinitrate ointment. Preliminary results].
Biagini A; Carpeggiani C; Testa R; Mazzei MG; Michelassi C; L'Abbate A
G Ital Cardiol; 1981; 11(7):983-9. PubMed ID: 7308655
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of some vascular diseases with the use of oxyphenyl-oxybutylamino-ethanol].
Berezovsky M; Berstein S
Prensa Med Argent; 1966 Sep; 53(36):1964-71. PubMed ID: 4384691
[No Abstract] [Full Text] [Related]
14. Clinical and haemorheological efficacy of i.a. PGE1 infusions in intermittent claudication.
Blume J; Kiesewetter H; Rühlmann U
Vasa Suppl; 1987; 17():32-5. PubMed ID: 3470963
[No Abstract] [Full Text] [Related]
15. [Sexual impotence of vascular origin in patients with obliterative arterial disease of the lower limbs].
Setacci C; Giubbolini G; Tanzini G; Silvestrini F; Iudicone R; Campoccia G; Palasciano G; de Nisi A
Angiologia; 1987; 39(2):80-3. PubMed ID: 3592293
[No Abstract] [Full Text] [Related]
16. 133-Xenon tests for evaluating obliterative arterial disease.
Lindbjerg IF
Scand J Clin Lab Invest Suppl; 1967; 100():77. PubMed ID: 6038157
[No Abstract] [Full Text] [Related]
17. [Experiences with the new vasotherapeutic drug Trental in dermatology].
Herger R
Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
[No Abstract] [Full Text] [Related]
18. [Removal of stenoses in the arteries of the extremities with intravenous streptokinase treatment].
Schoop W; Martin M; Zeitler E
Dtsch Med Wochenschr; 1968 Aug; 93(35):1629-33. PubMed ID: 5666886
[No Abstract] [Full Text] [Related]
19. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
Giulini SM; Agus GB; De Cristoforo A
Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
[No Abstract] [Full Text] [Related]
20. [On the treatment of intermittent claudication. Clinical studies of pharmacological effects].
Koppelmann J; Friedebold G
Med Klin; 1969 Jan; 64(5):199-202. PubMed ID: 5772759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
